{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:06:05Z","timestamp":1791925565452,"version":"4.3.4"},"reference-count":113,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Aging is the greatest risk factor for late-onset Alzheimer\u2019s disease (LOAD), which accounts for &gt;95% of Alzheimer\u2019s disease (AD) cases. The mechanism underlying the aging-related susceptibility to LOAD is unknown. Cellular senescence, a state of permanent cell growth arrest, is believed to contribute importantly to aging and aging-related diseases, including AD. Senescent astrocytes, microglia, endothelial cells, and neurons have been detected in the brain of AD patients and AD animal models. Removing senescent cells genetically or pharmacologically ameliorates \u03b2-amyloid (A\u03b2) peptide and tau-protein-induced neuropathologies, and improves memory in AD model mice, suggesting a pivotal role of cellular senescence in AD pathophysiology. Nonetheless, although accumulated evidence supports the role of cellular senescence in aging and AD, the mechanisms that promote cell senescence and how senescent cells contribute to AD neuropathophysiology remain largely unknown. This review summarizes recent advances in this field. We believe that the removal of senescent cells represents a promising approach toward the effective treatment of aging-related diseases, such as AD.<\/jats:p>","DOI":"10.3390\/ijms23041989","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T21:08:43Z","timestamp":1644786523000},"page":"1989","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":249,"title":["Aging, Cellular Senescence, and Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"23","author":[{"given":"Rui-Ming","family":"Liu","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0006, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: When bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1101\/gad.235184.113","article-title":"Cellular senescence and its effector programs","volume":"28","author":"Salama","year":"2014","journal-title":"Genes Dev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","article-title":"From discoveries in ageing research to therapeutics for healthy ageing","volume":"571","author":"Campisi","year":"2019","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular Senescence: Defining a Path Forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"dev151837","DOI":"10.1242\/dev.151837","article-title":"Cellular senescence in development, regeneration and disease","volume":"146","author":"Rhinn","year":"2019","journal-title":"Development"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular Senescence: Aging, Cancer, and Injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.18632\/aging.100413","article-title":"Molecular links between cellular senescence, longevity and age-related diseases\u2014A systems biology perspective","volume":"3","author":"Tacutu","year":"2011","journal-title":"Aging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders","volume":"479","author":"Baker","year":"2011","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: From mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.aaf6659","article-title":"Senescent intimal foam cells are deleterious at all stages of atherosclerosis","volume":"354","author":"Childs","year":"2016","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneph.2016.183","article-title":"Cellular senescence in renal ageing and disease","volume":"13","author":"Sturmlechner","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature16932","article-title":"Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan","volume":"530","author":"Baker","year":"2016","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbadis.2017.01.023","article-title":"Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer\u2019s neuropathology and cognitive deficits","volume":"1863","author":"Gerenu","year":"2017","journal-title":"Biochim. Biophys. Acta BBA-Mol. Basis Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41574-020-0335-y","article-title":"The role of cellular senescence in ageing and endocrine disease","volume":"16","author":"Khosla","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of Cellular Senescence","volume":"28","author":"Nehme","year":"2018","journal-title":"Trends Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI95145","article-title":"Cellular senescence in brain aging and neurodegenerative diseases: Evidence and perspectives","volume":"128","author":"Baker","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e13296","DOI":"10.1111\/acel.13296","article-title":"Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice","volume":"20","author":"Ogrodnik","year":"2021","journal-title":"Aging Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","article-title":"Inhibition of Bcl-2\/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice","volume":"99","author":"Pan","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1602367","DOI":"10.1183\/13993003.02367-2016","article-title":"Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo","volume":"50","author":"Lehmann","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI95146","article-title":"Senescent cells: A therapeutic target for cardiovascular disease","volume":"128","author":"Childs","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline","volume":"562","author":"Bussian","year":"2018","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates Abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.arr.2016.06.005","article-title":"A synopsis on aging-Theories, mechanisms and future prospects","volume":"29","author":"Vitorino","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1474-9726.2010.00666.x","article-title":"Age-associated increase in heterochromatic marks in murine and primate tissues","volume":"10","author":"Kreiling","year":"2011","journal-title":"Aging Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1474-9726.2009.00481.x","article-title":"DNA damage response and cellular senescence in tissues of aging mice","volume":"8","author":"Wang","year":"2009","journal-title":"Aging Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/gerona\/glu241","article-title":"Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs","volume":"71","author":"Calhoun","year":"2016","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature05159","article-title":"Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a","volume":"443","author":"Janzen","year":"2006","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature05091","article-title":"Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing","volume":"443","author":"Molofsky","year":"2006","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer\u2019s disease and other dementias: A priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","article-title":"Cellular senescence and Alzheimer disease: The egg and the chicken scenario","volume":"21","author":"Masliah","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_37","first-page":"1933","article-title":"Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer\u2019s disease","volume":"150","author":"McShea","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bhat, R., Crowe, E.P., Bitto, A., Moh, M., Katsetos, C.D., Garcia, F.U., Johnson, F.B., Trojanowski, J.Q., Sell, C., and Torres, C. (2012). Astrocyte senescence as a component of Alzheimer\u2019s disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045069"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/cdd.2016.37","article-title":"p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration","volume":"23","author":"Turnquist","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4103\/0366-6999.186646","article-title":"Amyloid beta Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer\u2019s Disease","volume":"129","author":"Wei","year":"2016","journal-title":"Chin. Med. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e12840","DOI":"10.1111\/acel.12840","article-title":"Tau protein aggregation is associated with cellular senescence in the brain","volume":"17","author":"Musi","year":"2018","journal-title":"Aging Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41593-019-0395-2","article-title":"Senescent glia spell trouble in Alzheimer\u2019s disease","volume":"22","author":"Holtzman","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnagi.2020.00148","article-title":"Astrocyte Senescence and Alzheimer\u2019s Disease: A Review","volume":"12","author":"Han","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mad.2005.08.006","article-title":"Chronically increased oxidative stress in fibroblasts from Alzheimer\u2019s disease patients causes early senescence and renders resistance to apoptosis by oxidative stress","volume":"127","author":"Naderi","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/nan.12156","article-title":"DNA damage response and senescence in endothelial cells of human cerebral cortex and relation to Alzheimer\u2019s neuropathology progression: A population-based study in the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort","volume":"40","author":"Garwood","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"109419","DOI":"10.1016\/j.celrep.2021.109419","article-title":"Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer\u2019s disease and frontotemporal dementia","volume":"36","author":"Gaikwad","year":"2021","journal-title":"Cell Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109228","DOI":"10.1016\/j.celrep.2021.109228","article-title":"Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology","volume":"35","author":"Hu","year":"2021","journal-title":"Cell Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb1448","article-title":"Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence","volume":"8","author":"Kortlever","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12052","DOI":"10.1073\/pnas.1120437109","article-title":"Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence","volume":"109","author":"Elzi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/acel.12247","article-title":"SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescence","volume":"13","author":"Wan","year":"2014","journal-title":"Aging Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1073\/pnas.1321942111","article-title":"PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice","volume":"111","author":"Eren","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/acel.12643","article-title":"Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease","volume":"16","author":"Jiang","year":"2017","journal-title":"Aging Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e44722","DOI":"10.15252\/embr.201744722","article-title":"Stress granules counteract senescence by sequestration of PAI-1","volume":"19","author":"Omer","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1165\/rcmb.2019-0071OC","article-title":"PAI-1 Regulation of TGF-beta1-induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages","volume":"62","author":"Rana","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"575953","DOI":"10.3389\/fneur.2020.575953","article-title":"Cerebrovascular Senescence Is Associated with Tau Pathology in Alzheimer\u2019s Disease","volume":"11","author":"Bryant","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.exger.2011.11.012","article-title":"Telomere length is age-dependent and reduced in monocytes of Alzheimer patients","volume":"47","author":"Hochstrasser","year":"2012","journal-title":"Exp. Gerontol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/gerona\/glw053","article-title":"Meta-analysis of Telomere Length in Alzheimer\u2019s Disease","volume":"71","author":"Forero","year":"2016","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3233\/JAD-190134","article-title":"Leukocyte Telomere Length Shortening and Alzheimer\u2019s Disease Etiology","volume":"69","author":"Guo","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000501958","article-title":"Association of Leukocyte Telomere Length with Mild Cognitive Impairment and Alzheimer\u2019s Disease: Role of Folate and Homocysteine","volume":"48","author":"Ma","year":"2019","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10654-019-00563-w","article-title":"Observational and genetic studies of short telomeres and Alzheimer\u2019s disease in 67,000 and 152,000 individuals: A Mendelian randomization study","volume":"35","author":"Rasmussen","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.18632\/aging.202206","article-title":"Relationship between telomere shortening and age in Korean individuals with mild cognitive impairment and Alzheimer\u2019s disease compared to that in healthy controls","volume":"13","author":"Lee","year":"2020","journal-title":"Aging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.18632\/aging.102893","article-title":"Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer\u2019s disease","volume":"12","author":"Koh","year":"2020","journal-title":"Aging"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.exger.2011.12.005","article-title":"Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer\u2019s disease: A pilot study","volume":"47","author":"Johansson","year":"2012","journal-title":"Exp. Gerontol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00702-017-1721-z","article-title":"Leukocyte telomere length is linked to vascular risk factors not to Alzheimer\u2019s disease in the VITA study","volume":"124","author":"Hinterberger","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_68","first-page":"260","article-title":"Telomere Shortening in Alzheimer\u2019s Disease Patients","volume":"46","author":"Liu","year":"2016","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/gerona\/glr185","article-title":"Association between ApoE phenotypes and telomere erosion in Alzheimer\u2019s disease","volume":"67","author":"Takata","year":"2012","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"733945","DOI":"10.3389\/fcell.2021.733945","article-title":"Clemastine Ameliorates Myelin Deficits via Preventing Senescence of Oligodendrocytes Precursor Cells in Alzheimer\u2019s Disease Model Mouse","volume":"9","author":"Xie","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e2011226118","DOI":"10.1073\/pnas.2011226118","article-title":"NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS-STING","volume":"118","author":"Hou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11064-009-9924-9","article-title":"Glutathionylation of the pro-apoptotic protein p53 in Alzheimer\u2019s disease brain: Implications for AD pathogenesis","volume":"34","author":"Cenini","year":"2009","journal-title":"Neurochem. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/acel.12565","article-title":"Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model","volume":"16","author":"Bodea","year":"2017","journal-title":"Aging Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exger.2016.12.017","article-title":"Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimers disease","volume":"88","author":"Scarabino","year":"2017","journal-title":"Exp. Gerontol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.18632\/aging.101982","article-title":"Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice","volume":"11","author":"Whittemore","year":"2019","journal-title":"Aging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1097-2765(04)00256-4","article-title":"Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a)","volume":"14","author":"Herbig","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fncel.2020.00129","article-title":"Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis","volume":"14","author":"Walton","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e924","DOI":"10.1038\/cddis.2013.437","article-title":"Amyloid-beta(1-42) oligomer accelerates senescence in adult hippocampal neural stem\/progenitor cells via formylpeptide receptor 2","volume":"4","author":"He","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"183061","DOI":"10.1016\/j.bbamem.2019.183061","article-title":"Nanomechanical insights: Amyloid beta oligomer-induced senescent brain endothelial cells","volume":"1861","author":"Kulkarni","year":"2019","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2017.05.055","article-title":"Galantamine alleviates senescence of U87 cells induced by beta-amyloid through decreasing ROS production","volume":"653","author":"Zhang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1096\/fj.201802003R","article-title":"VEGF receptor-1 modulates amyloid \u03b2 1-42 oligomer-induced senescence in brain endothelial cells","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"ref_85","first-page":"7698560","article-title":"A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer\u2019s Amyloid-beta-Induced Oxidative Stress, Mitochondrial Dysfunction, and Cell Senescence through Upregulating SIRT3","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3389\/fneur.2020.00929","article-title":"Interleukin-1beta Drives Cellular Senescence of Rat Astrocytes Induced by Oligomerized Amyloid beta Peptide and Oxidative Stress","volume":"11","author":"Shang","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1089\/rej.2018.2155","article-title":"Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration","volume":"21","author":"Mendelsohn","year":"2018","journal-title":"Rejuvenation Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1097\/00001756-199611250-00050","article-title":"Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer\u2019s disease","volume":"7","author":"Arendt","year":"1996","journal-title":"Neuroreport"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1196\/annals.1297.059","article-title":"Glutathione metabolism during aging and in Alzheimer disease","volume":"1019","author":"Liu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2010.04.011","article-title":"Preclinical Alzheimer disease: Brain oxidative stress, Abeta peptide and proteomics","volume":"39","author":"Aluise","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1089\/ars.2012.5039","article-title":"Mitochondrial DNA oxidative damage and repair in aging and Alzheimer\u2019s disease","volume":"18","author":"Santos","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.12.004","article-title":"Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients","volume":"91","author":"Pupo","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.02.030","article-title":"Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer\u2019s disease pathology","volume":"42","author":"Scheff","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"54","DOI":"10.14715\/cmb\/2019.65.8.9","article-title":"Benefit of an association of an antioxidative substrate and a traditional chinese medicine on telomere elongation","volume":"65","author":"Breton","year":"2019","journal-title":"Cell. Mol. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/acschemneuro.0c00775","article-title":"Olmesartan Prevents Oligomerized Amyloid beta (Abeta)-Induced Cellular Senescence in Neuronal Cells","volume":"12","author":"Wang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0038-1661557","article-title":"Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age","volume":"55","author":"Aillaud","year":"1986","journal-title":"Thromb. Haemost."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cardiores.2004.11.013","article-title":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: Implication in the pathogenesis of thrombotic disorders in the elderly","volume":"66","author":"Yamamoto","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.amjcard.2005.06.072","article-title":"Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study)","volume":"96","author":"Tofler","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0034-1384635","article-title":"Plasminogen activator inhibitor-1 in aging","volume":"40","author":"Yamamoto","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2009.06.003","article-title":"Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer\u2019s disease","volume":"32","author":"Liu","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.exger.2014.10.004","article-title":"Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer\u2019s disease","volume":"60","author":"Oh","year":"2014","journal-title":"Exp. Gerontol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JAD-180906","article-title":"Early-Stage Alzheimer\u2019s Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways","volume":"68","author":"Tong","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cns.13082","article-title":"Amyloid beta soluble forms and plasminogen activation system in Alzheimer\u2019s disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications","volume":"25","author":"Angelucci","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0039-1688444","article-title":"Hemostatic Abnormalities in Dementia: A Systematic Review and Meta-Analysis","volume":"45","author":"Loures","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","article-title":"The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration","volume":"23","author":"Melchor","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nbd.2007.04.004","article-title":"Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms","volume":"27","author":"Cacquevel","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2014.11.042","article-title":"Impacts of aging and amyloid-beta deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"1597","author":"Suh","year":"2015","journal-title":"Brain Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-180241","article-title":"A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-beta Load and Improves Memory in an Animal Model of Alzheimer\u2019s Disease","volume":"64","author":"Akhter","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"17595","DOI":"10.1074\/jbc.M109.001735","article-title":"Enhanced endothelial cell senescence by lithium-induced matrix metalloproteinase-1 expression","volume":"284","author":"Struewing","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","article-title":"Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence","volume":"37","author":"Vaughan","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jth.13689","article-title":"Plasminogen activator inhibitor-1 is associated with leukocyte telomere length in American Indians: Findings from the Strong Heart Family Study","volume":"15","author":"Peng","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"eaao1617","DOI":"10.1126\/sciadv.aao1617","article-title":"A null mutation in SERPINE1 protects against biological aging in humans","volume":"3","author":"Khan","year":"2017","journal-title":"Sci. Adv."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/1989\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:17:38Z","timestamp":1760134658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/1989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":113,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23041989"],"URL":"https:\/\/doi.org\/10.3390\/ijms23041989","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}